These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 34250834)

  • 61. Can Colchicine as an Old Anti-Inflammatory Agent Be Effective in COVID-19?
    Nasiripour S; Zamani F; Farasatinasab M
    J Clin Pharmacol; 2020 Jul; 60(7):828-829. PubMed ID: 32445400
    [No Abstract]   [Full Text] [Related]  

  • 62. Adding colchicine to tocilizumab in hospitalized patients with severe COVID-19 pneumonia: An open-label randomized controlled trial.
    Rahhal A; Najim M; Aljundi AH; Mahfouz A; Alyafei SM; Awaisu A; Habib MB; Obeidat I; Faisal MM; Alanzi MA; Nair AP; Elhassan A; Al-Dushain A; Abdelmajid AA; Abdelgader AE; Moursi AMA; Alharafsheh AEN; Kamar MRA; Goravey W; Omar AS; Abukhattab M; Khatib MY; Mohamedali MG; AlMaslamani MAR; Alemadi S
    Medicine (Baltimore); 2022 Sep; 101(39):e30618. PubMed ID: 36181009
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.
    Aflaki M; Flannery A; Ferreira JP; Cheng MP; Kronfli N; Marelli A; Zannad F; Brophy J; Afillalo J; Huynh T; Giannetti N; Bessissow A; Ezekowitz JA; Lopes RD; Ambrosy AP; Craig M; Sharma A
    Trials; 2021 Feb; 22(1):115. PubMed ID: 33546734
    [TBL] [Abstract][Full Text] [Related]  

  • 64. COVID-19: The Potential Role of Copper and N-acetylcysteine (NAC) in a Combination of Candidate Antiviral Treatments Against SARS-CoV-2.
    Andreou A; Trantza S; Filippou D; Sipsas N; Tsiodras S
    In Vivo; 2020 Jun; 34(3 Suppl):1567-1588. PubMed ID: 32503814
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Colchicine effectiveness in symptom and inflammation modification in knee osteoarthritis (COLKOA): study protocol for a randomized controlled trial.
    Leung YY; Thumboo J; Wong BS; Haaland B; Chowbay B; Chakraborty B; Tan MH; Kraus VB
    Trials; 2015 Apr; 16():200. PubMed ID: 25925674
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The proportion and effect of corticosteroid therapy in patients with COVID-19 infection: A systematic review and meta-analysis.
    Wang J; Yang W; Chen P; Guo J; Liu R; Wen P; Li K; Lu Y; Ma T; Li X; Qin S; Zhang Y; Wang Y
    PLoS One; 2021; 16(4):e0249481. PubMed ID: 33882090
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial.
    Garcia-Vicuña R; Abad-Santos F; González-Alvaro I; Ramos-Lima F; Sanz JS
    Trials; 2020 Sep; 21(1):772. PubMed ID: 32907638
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effects of colchicine on major adverse cardiac events in next 6-month period after acute coronary syndrome occurrence; a randomized placebo-control trial.
    Akrami M; Izadpanah P; Bazrafshan M; Hatamipour U; Nouraein N; Drissi HB; Manafi A
    BMC Cardiovasc Disord; 2021 Dec; 21(1):583. PubMed ID: 34876021
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Systemic corticosteroids for the treatment of COVID-19.
    Wagner C; Griesel M; Mikolajewska A; Mueller A; Nothacker M; Kley K; Metzendorf MI; Fischer AL; Kopp M; Stegemann M; Skoetz N; Fichtner F
    Cochrane Database Syst Rev; 2021 Aug; 8(8):CD014963. PubMed ID: 34396514
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Colchicine and the combination of rivaroxaban and aspirin in patients hospitalised with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial.
    Eikelboom JW; Jolly SS; Belley-Cote EP; Whitlock RP; Rangarajan S; Xu L; Heenan L; Bangdiwala SI; Luz Diaz M; Diaz R; Yusufali A; Kumar Sharma S; Tarhuni WM; Hassany M; Avezum A; Harper W; Wasserman S; Almas A; Drapkina O; Felix C; Lopes RD; Berwanger O; Lopez-Jaramillo P; Anand SS; Bosch J; Choudhri S; Farkouh ME; Loeb M; Yusuf S
    Lancet Respir Med; 2022 Dec; 10(12):1169-1177. PubMed ID: 36228641
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Colchicine Is Safe Though Ineffective in the Treatment of Severe COVID-19: a Randomized Clinical Trial (COLCHIVID).
    Absalón-Aguilar A; Rull-Gabayet M; Pérez-Fragoso A; Mejía-Domínguez NR; Núñez-Álvarez C; Kershenobich-Stalnikowitz D; Sifuentes-Osornio J; Ponce-de-León A; González-Lara F; Martín-Nares E; Montesinos-Ramírez S; Ramírez-Alemón M; Ramírez-Rangel P; Márquez MF; Plata-Corona JC; Juárez-Vega G; Gómez-Martín D; Torres-Ruiz J
    J Gen Intern Med; 2022 Jan; 37(1):4-14. PubMed ID: 34755269
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Colchicine for cardiovascular medicine: a systematic review and meta-analysis.
    Casula M; Andreis A; Avondo S; Vaira MP; Imazio M
    Future Cardiol; 2022 Aug; 18(8):647-659. PubMed ID: 35787150
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Oxygen Saturation in Hospitalized COVID-19 Patients and Its Relation to Colchicine Treatment: A Retrospective Cohort Study with an Updated Systematic Review.
    Sharaf S; Ashmawy R; Saleh E; Salama M; El-Maradny YA; Zari A; Aly S; Tolba A; Mahrous D; Elsayed H; Latif D; Redwan EM; Kamal E
    Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241167
    [No Abstract]   [Full Text] [Related]  

  • 74. Efficacy and safety of Ixekizumab vs. low-dose IL-2 vs. Colchicine vs. standard of care in the treatment of patients hospitalized with moderate-to-critical COVID-19: A pilot randomized clinical trial (STRUCK: Survival Trial Using Cytokine Inhibitors).
    Bonifácio LP; Ramacciotti E; Agati LB; Vilar FC; Silva ACTD; Louzada Júnior P; Fonseca BALD; Souza HCC; Oliveira CCC; Aguiar VCR; Quadros CAA; Dusilek C; Itinose K; Risson R; Ferreira LRR; Lopes RD; Kallas EG; Bellissimo-Rodrigues F
    Rev Soc Bras Med Trop; 2023; 56():e0565. PubMed ID: 37075454
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial.
    Eikelboom JW; Jolly SS; Belley-Cote EP; Whitlock RP; Rangarajan S; Xu L; Heenan L; Bangdiwala SI; Tarhuni WM; Hassany M; Kontsevaya A; Harper W; Sharma SK; Lopez-Jaramillo P; Dans AL; Palileo-Villanueva LM; Avezum A; Pais P; Xavier D; Felix C; Yusufali A; Lopes RD; Berwanger O; Ali Z; Wasserman S; Anand SS; Bosch J; Choudhri S; Farkouh ME; Loeb M; Yusuf S
    Lancet Respir Med; 2022 Dec; 10(12):1160-1168. PubMed ID: 36228639
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The evidence from clinical trials on colchicine and corticosteroids' effect on COVID-19: a systematic review and meta-analysis.
    Bitar AN; Sulaiman SAS
    Curr Med Res Opin; 2022 Dec; 38(12):2097-2108. PubMed ID: 35819071
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Home pharmacological therapy in early COVID-19 to prevent hospitalization and reduce mortality: Time for a suitable proposal.
    Pandolfi S; Chirumbolo S; Ricevuti G; Valdenassi L; Bjørklund G; Lysiuk R; Doşa MD; Lenchyk L; Fazio S
    Basic Clin Pharmacol Toxicol; 2022 Feb; 130(2):225-239. PubMed ID: 34811895
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Atorvastatin and Aspirin as Adjuvant Therapy in Patients with SARS-CoV-2 Infection: A structured summary of a study protocol for a randomised controlled trial.
    Ghati N; Roy A; Bhatnagar S; Bhati S; Bhushan S; Mahendran M; Thakur A; Tiwari P; Dwivedi T; Mani K; Gupta R; Mohan A; Garg R; Saxena A; Guleria R; Deepti S
    Trials; 2020 Oct; 21(1):902. PubMed ID: 33126910
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Interventions for reducing inflammation in familial Mediterranean fever.
    Wu B; Xu T; Li Y; Yin X
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD010893. PubMed ID: 30338514
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Anti-inflammatory therapies for pericardial diseases in the COVID-19 pandemic: safety and potentiality.
    Imazio M; Brucato A; Lazaros G; Andreis A; Scarsi M; Klein A; De Ferrari GM; Adler Y
    J Cardiovasc Med (Hagerstown); 2020 Sep; 21(9):625-629. PubMed ID: 32658005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.